Re-defining the role of chest physicians in lung cancer: new opportunities in diagnostics and therapy
Registration for this session is additional to the congress registration fee and is €268 on site, €244 standard
Aims : Access educational materials here
To highlight the most recent advances in diagnostics and therapy which every chest physician should be aware of when piloting and tailoring personalised care for lung cancer patients in a multi-professional setting; to provide an overview of the rapidly evolving lung cancer care with the goal of chronifying a so far almost devastating disease.
Target audience :
Allied health professional, Clinician, Emergency medicine doctor, Fellow, General practitioner, Immunologist, Intensivist/critical care physician, Junior member, Lung function technician, Nurse, Oncologist, Pathologist, Patient, Pulmonologist, Radiologist, Researcher, Resident, Respiratory physician, Respiratory therapist, Scientist, Student, Thoracic endoscopist, Thoracic surgeon, Trainee, Pharmaceutical industry representative